Literature DB >> 30868891

Exosomal miRNA423-5p mediated oncogene activity in papillary thyroid carcinoma: a potential diagnostic and biological target for cancer therapy.

W Ye1, X Deng1, Y Fan1.   

Abstract

Exosomes are considered important "messengers" between cells and their cargo, and some of the miRNAs composing their cargo may be involved in oncogenic activity. Exosomal miRNA423-5p (Ex-miRNA423-5p) is upregulated in gastric cancer and associated with its poor prognosis. However, the role of exosome-derived miRNAs in papillary thyroid cancer (PTC) is still unclear and needs further study. In our work, we found that the level of Ex-miRNA423-5p was significantly increased in the serum of PTC patients compared with the serum of normal healthy people, and in vitro, we demonstrated that miRNA423-5p entered thyroid cancer cells through exosomes from thyroid cancer cell supernatant. Functional experiments demonstrated that overexpression of miRNA423-5p mimics in exosomes increased PTC cell migration and invasion, while the silencing of miRNA423-5p in TPC-1 cell exosomes inhibited PTC cell migration and invasion in vitro. These findings indicate that Ex- miRNA423-5p might serve as a potential tumor marker; thus, silencing miRNA423-5p in exosomes might represent a potential approach against PTC.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30868891     DOI: 10.4149/neo_2018_180824N643

Source DB:  PubMed          Journal:  Neoplasma        ISSN: 0028-2685            Impact factor:   2.575


  7 in total

Review 1.  Circulating microRNAs and Clinicopathological Findings of Papillary Thyroid Cancer: A Systematic Review.

Authors:  Georgios Geropoulos; Kyriakos Psarras; Maria Papaioannou; Dimitrios Giannis; Maria Meitanidou; Konstantinos Kapriniotis; Nikolaos Symeonidis; Efstathios T Pavlidis; Theodoros E Pavlidis; Konstantinos Sapalidis; Nada Mabrouk Ahmed; Tarek Ezzat Abdel-Aziz; Mohammad M R Eddama
Journal:  In Vivo       Date:  2022 Jul-Aug       Impact factor: 2.406

2.  MicroRNA-203a-3p may prevent the development of thyroid papillary carcinoma via repressing MAP3K1 and activating autophagy.

Authors:  Lei Dai; Weidong Zhang; Xianjiang Wu; Shuihong Zhou
Journal:  J Clin Lab Anal       Date:  2022-05-06       Impact factor: 3.124

Review 3.  MicroRNAs in Papillary Thyroid Cancer: What Is New in Diagnosis and Treatment.

Authors:  Maria Papaioannou; Angeliki G Chorti; Anthoula Chatzikyriakidou; Kleanthis Giannoulis; Sohail Bakkar; Theodosios S Papavramidis
Journal:  Front Oncol       Date:  2022-02-03       Impact factor: 6.244

Review 4.  Roles of exosomes as drug delivery systems in cancer immunotherapy: a mini-review.

Authors:  Zhen Fang; Yixuan Ding; Zhigang Xue; Peijuan Li; Jia Li; Fei Li
Journal:  Discov Oncol       Date:  2022-08-13

Review 5.  Exosomes as Mediators of Cell-to-Cell Communication in Thyroid Disease.

Authors:  Yi Wang; Feng Xu; Jia-Yu Zhong; Xiao Lin; Su-Kang Shan; Bei Guo; Ming-Hui Zheng; Ling-Qing Yuan
Journal:  Int J Endocrinol       Date:  2020-04-28       Impact factor: 3.257

6.  Extracellular Vesicles as Signal Carriers in Malignant Thyroid Tumors?

Authors:  Małgorzata Grzanka; Anna Stachurska-Skrodzka; Anna Adamiok-Ostrowska; Ewa Gajda; Barbara Czarnocka
Journal:  Int J Mol Sci       Date:  2022-03-17       Impact factor: 5.923

7.  Construction and analysis of an aberrant lncRNA-miRNA-mRNA network associated with papillary thyroid cancer.

Authors:  Yanxia Jiang; Jiao Wang; Jian Chen; Jiancheng Wang; Jixiong Xu
Journal:  Medicine (Baltimore)       Date:  2020-11-06       Impact factor: 1.817

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.